1

January 30, 2007


Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549


Attention:  Angela Crane, Branch Chief


Regarding:  Eastman Kodak Company
            Form 10-K for the fiscal year ended December 31, 2005
            File No. 001-00087


Dear Ms. Crane:

Please find attached the Company's response to the Staff's
letter to me dated January 8, 2007.  If you have any
questions, please call Diane Wilfong (Kodak) at (585) 781-
5650, Laurence Hickey (Kodak) at (585) 724-3378 or Brian Lane
(Gibson, Dunn & Crutcher) at (202) 887-3646.

                              Sincerely,

                              /s/ Frank S. Sklarsky

                              Frank S. Sklarsky
                              Chief Financial Officer and
                              Executive Vice President


Attachment

cc: Brian Lane, Esq.


2

Form 10-K for the fiscal year ended December 31, 2005

General

1.   We refer you to the representation in your response letter
     dated December 15, 2006, that your line of non-destructive
     testing films and developing chemicals has the potential to
     be designated "dual use" by the Commerce Department's Bureau
     of Industry and Security.  Please advise us whether the
     referenced film-developing chemicals, which your foreign
     subsidiaries provide to Iran, Sudan, and/or Syria, can be
     used as agents or precursors for agents in chemical weapons.
     Please also clarify for us into which of these countries the
     film-developing chemicals are provided.

To the best of Eastman Kodak Company's ("Kodak") management's
knowledge, our non-destructive testing film developing chemicals
cannot be used as agents or precursors for agents in chemical
weapons.

Sales of small quantities (less than $5,000 per year) of these
chemicals were made by an overseas subsidiary of Kodak to
civilian customers in Syria in 2005 and 2006.